Profile
Dr. Romulo Colindres is a Chief Medical Officer at Vaxcyte, Inc. and a VP-Global Medical Affairs Lead for Zoster at GlaxoSmithKline Plc. He is on the Board of Directors at Ovoca Bio Plc. He received his graduate degree from Unc Gillings School of Global Public Health, an MBA from The Fuqua School of Business and a doctorate degree from UNC School of Medicine.
Romulo Colindres active positions
| Companies | Position | Start |
|---|---|---|
VitriVax, Inc.
VitriVax, Inc. BiotechnologyHealth Technology Operates as a formulation technology company that develops novel vaccines and vaccine formulations | Chief Executive Officer | - |
Former positions of Romulo Colindres
| Companies | Position | End |
|---|---|---|
Ovoca Bio Plc
Ovoca Bio Plc Pharmaceuticals: MajorHealth Technology Invests in biopharmaceutical projects | Director/Board Member | 30/12/2021 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/01/2019 |
| VAXCYTE, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Romulo Colindres
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Ovoca Bio Plc
Ovoca Bio Plc Pharmaceuticals: MajorHealth Technology Invests in biopharmaceutical projects | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The Fuqua School of Business
The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unc Gillings School of Global Public Health
Unc Gillings School of Global Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UNC School of Medicine
UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
VitriVax, Inc.
VitriVax, Inc. BiotechnologyHealth Technology Operates as a formulation technology company that develops novel vaccines and vaccine formulations | Health Technology |
- Stock Market
- Insiders
- Romulo Colindres
















